$3.62 Billion is the total value of Flagship Pioneering Inc.'s 17 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRNA | Sell | Moderna Inc | $2,184,161,000 | -14.7% | 30,871,524 | -22.6% | 60.34% | -18.9% |
| MCRB | Seres Therapeutics Inc | $610,696,000 | +494.8% | 21,571,764 | 0.0% | 16.87% | +465.3% | |
| KLDO | Kaleido Biosciences Inc | $214,323,000 | +49.0% | 19,360,710 | 0.0% | 5.92% | +41.7% | |
| DNLI | Sell | Denali Therapeutics Inc | $214,273,000 | +11.0% | 5,980,263 | -25.1% | 5.92% | +5.6% |
| RUBY | Rubius Therapeutics Inc | $191,866,000 | -16.2% | 38,296,526 | 0.0% | 5.30% | -20.3% | |
| EVLO | Evelo Biosciences Inc | $120,684,000 | +7.6% | 22,900,069 | 0.0% | 3.33% | +2.3% | |
| AXLA | Axcella Health Inc | $57,973,000 | -16.5% | 12,548,414 | 0.0% | 1.60% | -20.6% | |
| SYRS | Syros Pharmaceuticals Inc | $25,976,000 | -17.1% | 2,938,494 | 0.0% | 0.72% | -21.1% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Flagship Ventures Fund V General Partner LLC #1
- Flagship Ventures Fund IV General Partner LLC #2
- Noubar Afeyan #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SERES THERAPEUTICS INC | 29 | Q3 2023 | 68.0% |
| DENALI THERAPEUTICS INC | 24 | Q3 2023 | 50.9% |
| SYROS PHARMACEUTICALS INC | 24 | Q2 2022 | 27.3% |
| MODERNA INC | 20 | Q3 2023 | 76.9% |
| EVELO BIOSCIENCES INC | 20 | Q1 2023 | 41.2% |
| RUBIUS THERAPEUTICS INC | 18 | Q4 2022 | 60.7% |
| Axcella Health Inc | 17 | Q2 2023 | 3.5% |
| KALEIDO BIOSCIENCES INC | 13 | Q1 2022 | 9.5% |
| Foghorn Therapeutics Inc | 12 | Q3 2023 | 6.5% |
| Sana Biotechnology Inc | 11 | Q3 2023 | 18.4% |
View Flagship Pioneering Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-09-15 |
| 4 | 2023-08-15 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-07-13 |
| 13F-HR | 2023-05-15 |
| 4 | 2023-02-27 |
| 13F-HR | 2023-02-14 |
View Flagship Pioneering Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.